In partnership with the Academy and other organizations, the Infectious Diseases Society of America (IDSA) has published evidence-based recommendations that serve as a “one-stop” guide to indicated and contraindicated vaccines for most categories of immunocompromised children and adults.

Titled Clinical Practice Guideline for the Vaccination of the Immunocompromised Host, the recommendations were prepared by an international panel of pediatric and adult experts in infectious diseases, immunology, oncology, stem cell and solid organ transplant, gastroenterology, and rheumatology. The guideline poses 23 questions, and answers those questions with 122 recommendations. The strength of each recommendation is characterized as “strong” or “weak,” and the quality of the supporting evidence is indicated as “high,” “moderate,” “low” or “very low.”

Six tables outline recommendations for use of individual vaccines for patients with human immunodeficiency virus (HIV) infection, cancer, a solid organ or stem cell transplant, asplenia, an immune-mediated illness on immune suppressive medications, a...

You do not currently have access to this content.